How many institutions held IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

87 institutional investors reported IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Q: What does CUSIP 45258J102 represent in this 13F holders report?

CUSIP 45258J102 is the security identifier for IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258J102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 202,731,676
Total 13F shares: 28,564,750
Share change: +15,935,424
Total reported value: $695,567,285
Price per share: $24.35
Number of holders: 87
Value change: +$388,041,409
Number of buys: 75
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 45258J102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	2.2%	4,426,106	$65,876,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.5%	1,020,000	$15,876,000	—	31 Mar 2020	13F
BVF INC/IL	13F	Company	0.49%	999,996	$15,565,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.45%	902,967	$14,055,000	—	31 Mar 2020	13F
Ikarian Capital, LLC	13F	Company	0.42%	842,463	$13,113,000	—	31 Mar 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.35%	710,000	$11,051,000	—	31 Mar 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.3%	609,399	$9,485,000	—	31 Mar 2020	13F
MANGROVE PARTNERS IM, LLC	13F	Company	0.28%	571,942	$8,902,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.23%	457,076	$7,114,000	—	31 Mar 2020	13F
Polar Capital LLP	13F	Company	0.22%	450,000	$7,004,000	—	31 Mar 2020	13F
Woodline Partners LP	13F	Company	0.16%	325,183	$5,061,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	0.12%	250,000	$3,891,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.09%	179,500	$2,794,000	—	31 Mar 2020	13F
Prosight Management, LP	13F	Company	0.06%	121,429	$1,890,000	—	31 Mar 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.06%	119,604	$1,862,000	—	31 Mar 2020	13F
Sio Capital Management, LLC	13F	Company	0.06%	114,133	$1,776,000	—	31 Mar 2020	13F
Eversept Partners, LP	13F	Company	0.04%	76,866	$1,196,419	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	73,842	$1,149,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	55,154	$858,000	—	31 Mar 2020	13F
Parkman Healthcare Partners LLC	13F	Company	0.02%	40,125	$625,000	—	31 Mar 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	36,100	$562,000	—	31 Mar 2020	13F
Granite Point Capital Management, L.P.	13F	Company	0.02%	35,000	$545,000	—	31 Mar 2020	13F
HSBC HOLDINGS PLC	13F	Company	0.01%	28,742	$447,000	—	31 Mar 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.01%	23,392	$364,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.01%	21,631	$337,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.01%	20,176	$314,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	19,175	$298,000	—	31 Mar 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.01%	19,032	$296,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	17,756	$276,000	—	31 Mar 2020	13F
Quantitative Systematic Strategies LLC	13F	Company	0.01%	15,509	$241,000	—	31 Mar 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	11,990	$186,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	0.01%	11,036	$172,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	8,412	$131,000	—	31 Mar 2020	13F
SIGNATUREFD, LLC	13F	Company	0%	3,500	$54,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	0%	3,208	$50,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0%	2,908	$45,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0%	2,357	$37,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0%	1,628	$25,000	—	31 Mar 2020	13F
Lindbrook Capital, LLC	13F	Company	0%	1,000	$16,000	—	31 Mar 2020	13F
Cubist Systematic Strategies, LLC	13F	Company	0%	339	$5,000	—	31 Mar 2020	13F

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2020

As of 30 Jun 2020, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,564,750 shares. The largest 10 holders included RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., Polar Capital LLP, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, BVF INC/IL, DRIEHAUS CAPITAL MANAGEMENT LLC, and Camber Capital Management LP. This page lists 87 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.